Cargando…
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
Gleich’s syndrome (GS) is characterized by recurrent episodes of angioedema, increase in body weight, fever, hypereosinophilia, and elevated serum IgM. The exact etiology remains unclear. Currently, the only treatment strategy is the administration of high dose of steroids during the acute phases. W...
Autores principales: | Matucci, Andrea, Liotta, Francesco, Vivarelli, Emanuele, Dies, Laura, Annunziato, Francesco, Piccinni, Marie Pierre, Nencini, Francesca, Pratesi, Sara, Maggi, Enrico, Vultaggio, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986952/ https://www.ncbi.nlm.nih.gov/pubmed/29896203 http://dx.doi.org/10.3389/fimmu.2018.01198 |
Ejemplares similares
-
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020) -
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis
por: Pratesi, Sara, et al.
Publicado: (2019) -
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
por: Vultaggio, Alessandra, et al.
Publicado: (2021) -
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
por: Vultaggio, Alessandra, et al.
Publicado: (2021) -
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
por: Matucci, Andrea, et al.
Publicado: (2021)